Only logged-in users can see full content details
ZAGREB, 8 March (Hina) - The Jadran Galenski Laboratorij (JGL) Group in 2021 registered HRK 1.1 billion in revenues and a pretax profit of HRK 105.7 million, the best ever business results of the leading Croatian pharma company.